Human brain myelination and amyloid beta deposition in Alzheimer’s disease

We hypothesized that myelin breakdown in vulnerable late‐myelinating regions releases oligodendrocyte‐ and myelin‐associated iron that promotes amyloid beta (Aβ) oligomerization, its associated toxicity, and the deposition of oligomerized Aβ and iron in neuritic plaques observed in Alzheimer's disease (AD). The model was tested by using published maps of cortical myelination from 1901 and recent in vivo imaging maps of Aβ deposits in humans. The data show that in AD, radiolabeled ligands detect Aβ deposition in a distribution that matches the map of late‐myelinating regions. Furthermore, the strikingly lower ability of this imaging ligand to bind Aβ in animal models is consistent with the much lower levels of myelin and associated iron levels in rodents when compared with humans. The hypotheses derived from the “myelin model” are testable with current imaging methods and have important implications for therapeutic interventions that should be expanded to include novel targets such as oligodendrocytes, myelin, and brain iron.

[1]  Vijaya L. Melnick,et al.  Alzheimer’s Dementia , 1985, Contemporary Issues in Biomedicine, Ethics, and Society.

[2]  G. Bartzokis,et al.  Heterogeneous age-related breakdown of white matter structural integrity: implications for cortical “disconnection” in aging and Alzheimer’s disease , 2004, Neurobiology of Aging.

[3]  A. Meyer Paul Flechsig’s System of Myelogenetic Cortical Localization in the Light of Recent Research in Neuroanatomy and Neurophysiology Part I , 1981, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[4]  C. Masters,et al.  Overexpression of Alzheimer's Disease Amyloid-β Opposes the Age-dependent Elevations of Brain Copper and Iron* , 2002, The Journal of Biological Chemistry.

[5]  Jim Mintz,et al.  Apolipoprotein E genotype and age-related myelin breakdown in healthy individuals: implications for cognitive decline and dementia. , 2006, Archives of general psychiatry.

[6]  W H Oldendorf,et al.  Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores , 1993, Magnetic resonance in medicine.

[7]  B. Tycko,et al.  Earlier onset of Alzheimer's disease in men with Down syndrome , 1998, Neurology.

[8]  C. Quintana,et al.  Study of the localization of iron, ferritin, and hemosiderin in Alzheimer's disease hippocampus by analytical microscopy at the subcellular level. , 2006, Journal of structural biology.

[9]  Janice E. Knoefel,et al.  Clinical neurology of aging , 1985 .

[10]  D. Sparks Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer’s-like amyloid β in rabbit brain , 2007, Journal of Molecular Neuroscience.

[11]  Benjamin J. Shannon,et al.  Molecular, Structural, and Functional Characterization of Alzheimer's Disease: Evidence for a Relationship between Default Activity, Amyloid, and Memory , 2005, The Journal of Neuroscience.

[12]  S. LeVine,et al.  The distribution of iron in the brain: a phylogenetic analysis using iron histochemistry. , 1996, Brain research. Developmental brain research.

[13]  S. DeKosky,et al.  Binding of the Positron Emission Tomography Tracer Pittsburgh Compound-B Reflects the Amount of Amyloid-β in Alzheimer's Disease Brain But Not in Transgenic Mouse Brain , 2005, The Journal of Neuroscience.

[14]  Joseph A. Helpern,et al.  Histological Co-Localization of Iron in Aß Plaques of PS/APP Transgenic Mice , 2005, Neurochemical Research.

[15]  Xudong Huang,et al.  Trace metal contamination initiates the apparent auto-aggregation, amyloidosis, and oligomerization of Alzheimer’s Aβ peptides , 2004, JBIC Journal of Biological Inorganic Chemistry.

[16]  Jim Mintz,et al.  Brain ferritin iron may influence age- and gender-related risks of neurodegeneration , 2007, Neurobiology of Aging.

[17]  G. Bartzokis,et al.  In vivo MR evaluation of age-related increases in brain iron. , 1994, AJNR. American journal of neuroradiology.

[18]  S. Love,et al.  Contributors to white matter damage in the frontal lobe in Alzheimer's disease , 2005, Neuropathology and applied neurobiology.

[19]  M. Schrag,et al.  Deposition of iron and β‐amyloid plaques is associated with cortical cellular damage in rabbits fed with long‐term cholesterol‐enriched diets , 2006, Journal of neurochemistry.

[20]  D. Larry Sparks Cholesterol, copper, and accumulation of thioflavine S-reactive Alzheimer's-like amyloid beta in rabbit brain. , 2004, Journal of molecular neuroscience : MN.

[21]  Marc Dhenain,et al.  Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease , 2006, Neurobiology of Disease.

[22]  Jim Mintz,et al.  Brain ferritin iron as a risk factor for age at onset in neurodegenerative diseases , 2005, Alzheimer's & Dementia.

[23]  George Bartzokis,et al.  Quadratic trajectories of brain myelin content: unifying construct for neuropsychiatric disorders , 2004, Neurobiology of Aging.

[24]  G. Bartzokis,et al.  MR evaluation of age-related increase of brain iron in young adult and older normal males. , 1997, Magnetic resonance imaging.

[25]  Imran Akram,et al.  Evidence and mechanisms of retrogenesis in Alzheimer's and other dementias: Management and treatment import , 2002, American journal of Alzheimer's disease and other dementias.

[26]  J. Connor,et al.  Relationship of iron to oligodendrocytes and myelination. , 1996, Glia.

[27]  B. Pakkenberg,et al.  Marked loss of myelinated nerve fibers in the human brain with age , 2003, The Journal of comparative neurology.

[28]  P. Zandi,et al.  Incidence of AD may decline in the early 90s for men, later for women , 2002, Neurology.

[29]  P D Griffiths,et al.  Iron in the basal ganglia in Parkinson's disease. An in vitro study using extended X-ray absorption fine structure and cryo-electron microscopy. , 1999, Brain : a journal of neurology.

[30]  N. Martin,et al.  Relative importance of female‐specific and non‐female‐specific effects on variation in iron stores between women , 2003, British journal of haematology.

[31]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[32]  P. Rakić,et al.  Cytological and quantitative characteristics of four cerebral commissures in the rhesus monkey , 1990, The Journal of comparative neurology.

[33]  A. Meyer,et al.  Paul Flechsig’s System of Myelogenetic Cortical Localization In the Light of Recent Research in Neuroanatomy and Neurophysiology Part II , 1981, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[34]  H. Braak,et al.  Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesis , 1996, Acta Neuropathologica.

[35]  P. Doraiswamy,et al.  Metals in our minds: therapeutic implications for neurodegenerative disorders , 2004, The Lancet Neurology.

[36]  J. Wesson Ashford,et al.  ApoE genotype accounts for the vast majority of AD risk and AD pathology , 2004, Neurobiology of Aging.

[37]  J. Ryu,et al.  Amyloid beta peptide-induced corpus callosum damage and glial activation in vivo. , 2003, Neuroreport.

[38]  Marc Dhenain,et al.  In vivo MRI and histological evaluation of brain atrophy in APP/PS1 transgenic mice , 2006, Neurobiology of Aging.

[39]  T. Kemper,et al.  Neuroanatomical and neuropathological changes during aging and dementia. , 1994 .

[40]  J. de Vellis,et al.  Dietary iron and the integrity of the developing rat brain: a study with the artificially-reared rat pup. , 2000, Cellular and molecular biology.

[41]  P Z Marmarelis,et al.  MRI evaluation of brain iron in earlier- and later-onset Parkinson's disease and normal subjects. , 1999, Magnetic resonance imaging.

[42]  G. Bartzokis BRAIN MYELINATION IN PREVALENT NEUROPSYCHIATRIC DEVELOPMENTAL DISORDERS: PRIMARY AND COMORBID ADDICTION. , 2005, Adolescent psychiatry.

[43]  H. Damasio,et al.  Humans and great apes share a large frontal cortex , 2002, Nature Neuroscience.

[44]  J. Connor,et al.  Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.

[45]  Clifford R Jack,et al.  In Vivo Magnetic Resonance Microimaging of Individual Amyloid Plaques in Alzheimer's Transgenic Mice , 2005, The Journal of Neuroscience.

[46]  B. Pakkenberg,et al.  Age-Induced White Matter Changes in the Human Brain: A Stereological Investigation , 1997, Neurobiology of Aging.

[47]  G. Percheron,et al.  Topographical and cytological localization of iron in rat and monkey brains , 1981, Brain Research.

[48]  B. Hallgren,et al.  THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.

[49]  G. Arendash,et al.  Time-dependent changes in iron levels and associated neuronal loss within the substantia nigra following lesions within the neostriatum/globus pallidus complex , 1995, Neuroscience.

[50]  M. Mattson,et al.  Presenilin-1 mutation sensitizes oligodendrocytes to glutamate and amyloid toxicities, and exacerbates white matter damage and memory impairment in mice , 2007, NeuroMolecular Medicine.

[51]  V. Swayze,et al.  Two Hemispheres—One Brain: Functions of the Corpus Callosum , 1987 .

[52]  G. Bartzokis Age-related myelin breakdown: a developmental model of cognitive decline and Alzheimer’s disease , 2004, Neurobiology of Aging.

[53]  P. Schoenemann,et al.  Prefrontal white matter volume is disproportionately larger in humans than in other primates , 2005, Nature Neuroscience.

[54]  B. Tycko,et al.  Onset of dementia is associated with age at menopause in women with Down's syndrome , 2003, Annals of neurology.

[55]  P. Gosling,et al.  Role of iron in Alzheimer‐type dementia in Down Syndrome , 1998, International journal of geriatric psychiatry.

[56]  Ya Ke,et al.  Iron misregulation in the brain: a primary cause of neurodegenerative disorders , 2003, The Lancet Neurology.

[57]  J. Connor,et al.  Redox-active metals in neurological disorders , 2004 .

[58]  Janice E. Knoefel,et al.  Clinical neurology of aging, 2nd ed. , 1994 .